Detection of six serotypes of botulinum neurotoxin using fluorogenic reporters

Analytical Biochemistry

Volumn 411, Issue 2, 2011, Pages 200-209

  Ruge, Daniel R ^a   Dunning, F Mark ^a   Piazza, Timothy M ^a,b   Molles, Brian E ^c   Adler, Michael ^c   Zeytin, Füsûn N ^a   Tucker, Ward C ^a  

^a BioSentinel Pharmaceuticals   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

Author keywords

Botulinum neurotoxin; FRET; High throughput assays; Proteases

Indexed keywords

BIOCHEMISTRY; CHEMISTRY;

BOTULINUM NEUROTOXINS; FEMTOMOLAR CONCENTRATION; FRET; HIGH THROUGHPUT SCREENING; HIGH-THROUGHPUT ASSAYS; INTER-ASSAY COEFFICIENTS; PHARMACEUTICAL APPLICATIONS; PROTEASES;

ANIMALS;

BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; BOTULINUM TOXIN D; BOTULINUM TOXIN E; BOTULINUM TOXIN F; BOTULINUM TOXIN G; SYNAPTOBREVIN; UNCLASSIFIED DRUG;

ARTICLE; ASSAY; FLUORESCENCE RESONANCE ENERGY TRANSFER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SEROTYPE;

ANIMALIA;

EID: 79952455057     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2011.01.002     Document Type: Article

References (63)

1. G. Schiavo, F. Benfenati, B. Poulain, O. Rossetto, P. Polverino de Laureto, B.R. DasGupta, and C. Montecucco Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin Nature 359 1992 832 835
2. J. Blasi, E.R. Chapman, E. Link, T. Binz, S. Yamasaki, P. De Camilli, T.C. Sudhof, H. Niemann, and R. Jahn Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25 Nature 365 1993 160 163 (Pubitemid 23282061)
3. J. Blasi, E.R. Chapman, S. Yamasaki, T. Binz, H. Niemann, and R. Jahn Botulinum neurotoxin C1 blocks neurotransmitter release by means of cleaving HPC-1/syntaxin EMBO J. 12 1993 4821 4828 (Pubitemid 23330288)
4. G. Schiavo, O. Rossetto, S. Catsicas, P. Polverino de Laureto, B.R. DasGupta, F. Benfenati, and C. Montecucco Identification of the nerve terminal targets of botulinum neurotoxin serotypes A, D, and E J. Biol. Chem. 268 1993 23784 23787 (Pubitemid 23335346)
5. G. Schiavo, C.C. Shone, O. Rossetto, F.C. Alexander, and C. Montecucco Botulinum neurotoxin serotype F is a zinc endopeptidase specific for VAMP/synaptobrevin J. Biol. Chem. 268 1993 11516 11519 (Pubitemid 23168093)
6. O. Rossetto, G. Schiavo, C. Montecucco, B. Poulain, F. Deloye, L. Lozzi, and C.C. Shone SNARE motif and neurotoxins Nature 372 1994 415 416
7. S. Yamasaki, A. Baumeister, T. Binz, J. Blasi, E. Link, F. Cornille, B. Roques, E.M. Fykse, T.C. Sudhof, and R. Jahn Cleavage of members of the synaptobrevin/VAMP family by types D and F botulinal neurotoxins and tetanus toxin J. Biol. Chem. 269 1994 12764 12772 (Pubitemid 24202070)
8. G. Schiavo, C. Malizio, W.S. Trimble, P. Polverino de Laureto, G. Milan, H. Sugiyama, E.A. Johnson, and C. Montecucco Botulinum G neurotoxin cleaves VAMP/synaptobrevin at a single Ala-Ala peptide bond J. Biol. Chem. 269 1994 20213 20216 (Pubitemid 24260411)
9. J. Sobel Botulism, Clin. Infect. Dis. 41 2005 1167 1173
10. R.A. Greenfield, B.R. Brown, J.B. Hutchins, J.J. Iandolo, R. Jackson, L.N. Slater, and M.S. Bronze Microbiological, biological, and chemical weapons of warfare and terrorism Am. J. Med. Sci. 323 2002 326 340 (Pubitemid 34651570)
11. S.S. Arnon, R. Schechter, T.V. Inglesby, D.A. Henderson, J.G. Bartlett, M.S. Ascher, E. Eitzen, A.D. Fine, J. Hauer, M. Layton, S. Lillibridge, M.T. Osterholm, T. O'Toole, G. Parker, T.M. Perl, P.K. Russell, D.L. Swerdlow, and K. Tonat Botulinum toxin as a biological weapon: medical and public health management JAMA 285 2001 1059 1070 (Pubitemid 32176420)
12. L.M. Wein, and Y. Liu Analyzing a bioterror attack on the food supply: the case of botulinum toxin in milk Proc. Natl. Acad. Sci. USA 102 2005 9984 9989 (Pubitemid 40993679)
13. P. Bossi, D. Garin, A. Guihot, F. Gay, J.M. Crance, T. Debord, B. Autran, and F. Bricaire Bioterrorism: management of major biological agents Cell. Mol. Life Sci. 63 2006 2196 2212 (Pubitemid 44653033)
14. R. Benecke, and D. Dressler Botulinum toxin treatment of axial and cervical dystonia Disabil. Rehabil. 29 2007 1769 1777 (Pubitemid 350176808)
15. D. Sinha, K. Karri, and A.S. Arunkalaivanan Applications of botulinum toxin in urogynaecology Eur. J. Obstet. Gynecol. Reprod. Biol. 133 2007 4 11 (Pubitemid 46962882)
16. S.T. Mahajan, and L. Brubaker Botulinum toxin: from life-threatening disease to novel medical therapy Am. J. Obstet. Gynecol. 196 2007 7 15 (Pubitemid 46107394)
17. R. Dmochowski, and P.K. Sand Botulinum toxin A in the overactive bladder: current status and future directions BJU Intl. 99 2007 247 262 (Pubitemid 46103100)
18. D.A. Kautter, and H.M. Solomon Collaborative study of a method for the detection of Clostridium botulinum and its toxins in foods J. Assoc. Anal. Chem. 60 1976 541 545
19. AOAC International Clostridium botulinum and its toxins in foods (method 977.26, section 17.7.01) W. Horwitz, Official Methods of Analysis of AOAC International 17th ed. 2001 Gaithersburg MD
20. E.J. Schantz, and D.A. Kautter Microbiological methods: standardized assay for Clostridium botulinum toxins J. AOAC 61 1978 96 99
21. S. Notermans, and J. Nagel Assays for botulinum and tetanus toxins L.L. Simpson, Botulinum Neurotoxin and Tetanus Toxin 1989 Academic Press New York 319 331
22. J.L. Ferreira Comparison of amplified ELISA and mouse bioassay procedures for determination of botulinal toxins A, B, E, and F J. AOAC Intl. 84 2001 85 88 (Pubitemid 33690667)
23. S. Cai, B.R. Singh, and S. Sharma Botulism diagnostics: from clinical symptoms to in vitro assays Crit. Rev. Microbiol. 33 2007 109 125 (Pubitemid 46897714)
24. A.E. Boyer, H. Moura, A.R. Woolfitt, S.R. Kalb, L.G. McWilliams, A. Pavlopoulos, J.G. Schmidt, D.L. Ashley, and J.R. Barr From the mouse to the mass spectrometer: detection and differentiation of the endoproteinase activities of botulinum neurotoxins A-G by mass spectrometry Anal. Chem. 77 2005 3916 3924 (Pubitemid 40934253)
25. S.R. Kalb, H. Moura, A.E. Boyer, L.G. McWilliams, J.L. Pirkle, and J.R. Barr The use of Endopep-MS for the detection of botulinum toxins A, B, E, and F in serum and stool samples Anal. Biochem. 351 2006 84 92
26. C. Anne, F. Cornille, C. Lenoir, and B.P. Roques High-throughput fluorogenic assay for determination of botulinum type B neurotoxin protease activity Anal. Biochem. 291 2001 253 261 (Pubitemid 32373160)
27. J.J. Schmidt, R.G. Stafford, and C.B. Millard High-throughput assays for botulinum neurotoxin proteolytic activity: serotypes A, B, D, and F Anal. Biochem. 296 2001 130 137 (Pubitemid 32808404)
28. J.J. Schmidt, and R.G. Stafford Fluorigenic substrates for the protease activities of botulinum neurotoxins, serotypes A, B, and F Appl. Environ. Microbiol. 69 2003 297 303 (Pubitemid 36077488)
29. M. Pires-Alves, M. Ho, K.K. Aberle, K.D. Janda, and B.A. Wilson Tandem fluorescent proteins as enhanced FRET-based substrates for botulinum neurotoxin activity Toxicon 53 2009 392 399
30. N.T. Salzameda, J.T. Barbieri, and K.D. Janda Synthetic substrate for application in both high and low throughput assays for botulinum neurotoxin B protease inhibitors Bioorg. Med. Chem. Lett. 19 2009 5848 5850
31. H. Poras, T. Ouimet, S.V. Orng, M.C. Fournie-Zaluski, M.R. Popoff, and B.P. Roques Detection and quantification of botulinum neurotoxin type A by a novel rapid in vitro fluorimetric assay Appl. Environ. Microbiol. 75 2009 4382 4390
32. M. Dong, W.H. Tepp, E.A. Johnson, and E.R. Chapman Using fluorescent sensors to detect botulinum neurotoxin activity in vitro and in living cells Proc. Natl. Acad. Sci. USA 101 2004 14701 14706 (Pubitemid 39410738)
33. T.G. Schmidt, and A. Skerra The Strep-Tag system for one-step purification and high-affinity detection or capturing of proteins Nat. Protoc. 2 2007 1528 1535 (Pubitemid 46952331)
34. T. Nagai, K. Ibata, E.S. Park, M. Kubota, K. Mikoshiba, and A. Miyawaki A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications Nat. Biotechnol. 20 2002 87 90 (Pubitemid 34044921)
35. D.A. Zacharias, J.D. Violin, A.C. Newton, and R.Y. Tsien Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells Science 296 2002 913 916 (Pubitemid 34464897)
36. J.L. Vinkenborg, T.H. Evers, S.W. Reulen, E.W. Meijer, and M. Merkx Enhanced sensitivity of FRET-based protease sensors by redesign of the GFP dimerization interface Chem. BioChem. 8 2007 1119 1121 (Pubitemid 47194817)
37. J.R. Lakowicz Principles of Fluorescence Spectroscopy 1999 Kluwer Academic/Plenum New York
38. T.B. Helting, S. Parschat, and H. Engelhardt Structure of tetanus toxin: demonstration and separation of a specific enzyme converting intracellular tetanus toxin to the extracellular form J. Biol. Chem. 254 1979 10728 10733 (Pubitemid 10159368)
39. U. Weller, M.E. Dauzenroth, D. Meyer zu Heringdorf, and E. Habermann Chains and fragments of tetanus toxin: separation, reassociation, and pharmacological properties Eur. J. Biochem. 182 1989 649 656 (Pubitemid 19169959)
40. G. Schiavo, M. Matteoli, and C. Montecucco Neurotoxins affecting neuroexocytosis, Physiol. Rev. 80 2000 717 766
41. D. Sesardic, T. Leung, and R. Gaines Das Role for standards in assays of botulinum toxins: international collaborative study of three preparations of botulinum type A toxin Biologicals 31 2003 265 276 (Pubitemid 37414922)
42. P. Washbourne, R. Pellizzari, G. Baldini, M.C. Wilson, and C. Montecucco Botulinum neurotoxin types A and E require the SNARE motif in SNAP-25 for proteolysis FEBS Lett. 418 1997 1 5 (Pubitemid 27514402)
43. R. Agarwal, T. Binz, and S. Swaminathan Analysis of active site residues of botulinum neurotoxin E by mutational, functional, and structural studies: Glu335Gln is an apoenzyme Biochemistry 44 2005 8291 8302 (Pubitemid 40799910)
44. S. Chen, and J.T. Barbieri Unique substrate recognition by botulinum neurotoxin serotypes A and E J. Biol. Chem. 281 2006 10906 10911 (Pubitemid 43855514)
45. 365 of the botulinum neurotoxin type A light chain are involved in transition state stabilization Biochemistry 41 2002 1717 1723 (Pubitemid 34132245)
46. L. Li, T. Binz, H. Niemann, and B.R. Singh Probing the mechanistic role of glutamate residue in the zinc-binding motif of type A botulinum neurotoxin light chain Biochemistry 39 2000 2399 2405 (Pubitemid 30130092)
47. S. Sikorra, T. Henke, T. Galli, and T. Binz Substrate recognition mechanism of VAMP/synaptobrevin-cleaving clostridial neurotoxins J. Biol. Chem. 283 2008 21145 21152
48. S. Chen, C. Hall, and J.T. Barbieri Substrate recognition of VAMP-2 by botulinum neurotoxin B and tetanus neurotoxin J. Biol. Chem. 283 2008 21153 21159
49. M.R. Baldwin, M. Bradshaw, E.A. Johnson, and J.T. Barbieri The C-terminus of botulinum neurotoxin type A light chain contributes to solubility, catalysis, and stability Protein Expr. Purif. 37 2004 187 195 (Pubitemid 39027259)
50. J.S. Henkel, M. Jacobson, W. Tepp, C. Pier, E.A. Johnson, and J.T. Barbieri Catalytic properties of botulinum neurotoxin subtypes A3 and A4 Biochemistry 48 2009 2522 2528
51. L.M. Eubanks, M.S. Hixon, W. Jin, S. Hong, C.M. Clancy, W.H. Tepp, M.R. Baldwin, C.J. Malizio, M.C. Goodnough, J.T. Barbieri, E.A. Johnson, D.L. Boger, T.J. Dickerson, and K.D. Janda An in vitro and in vivo disconnect uncovered through high-throughput identification of botulinum neurotoxin A antagonists Proc. Natl. Acad. Sci. USA 104 2007 2602 2607 (Pubitemid 46327926)
52. G.E. Boldt, J.P. Kennedy, M.S. Hixon, L.A. McAllister, J.T. Barbieri, S. Tzipori, and K.D. Janda Synthesis, characterization, and development of a high-throughput methodology for the discovery of botulinum neurotoxin A inhibitors J. Comb. Chem. 8 2006 513 521 (Pubitemid 44116114)
53. J.H. Zhang, T.D. Chung, and K.R. Oldenburg A simple statistical parameter for use in evaluation and validation of high throughput screening assays J. Biomol. Screen. 4 1999 67 73 (Pubitemid 29278954)
54. J.C. Burnett, E.A. Henchal, A.L. Schmaljohn, and S. Bavari The evolving field of biodefense: therapeutic developments and diagnostics Nat. Rev. Drug Discov. 4 2005 281 297 (Pubitemid 41135787)
55. J.C. Burnett, C. Wang, J.E. Nuss, T.L. Nguyen, A.R. Hermone, J.J. Schmidt, R. Gussio, P. Wipf, and S. Bavari Pharmacophore-guided lead optimization: the rational design of a non-zinc coordinating, sub-micromolar inhibitor of the botulinum neurotoxin serotype A metalloprotease Bioorg. Med. Chem. Lett. 19 2009 5811 5813
56. J.C. Burnett, G. Ruthel, C.M. Stegmann, R.G. Panchal, T.L. Nguyen, A.R. Hermone, R.G. Stafford, D.J. Lane, T.A. Kenny, C.F. McGrath, P. Wipf, A.M. Stahl, J.J. Schmidt, R. Gussio, A.T. Brunger, and S. Bavari Inhibition of metalloprotease botulinum serotype A from a pseudo-peptide binding mode to a small molecule that is active in primary neurons J. Biol. Chem. 282 2007 5004 5014 (Pubitemid 47100957)
57. A.R. Hermone, J.C. Burnett, J.E. Nuss, L.E. Tressler, T.L. Nguyen, B.A. Solaja, J.L. Vennerstrom, J.J. Schmidt, P. Wipf, S. Bavari, and R. Gussio Three-dimensional database mining identifies a unique chemotype that unites structurally diverse botulinum neurotoxin serotype A inhibitors in a three-zone pharmacophore Chem. Med. Chem. 3 2008 1905 1912
58. C. Anne, S. Turcaud, J. Quancard, F. Teffo, H. Meudal, M.C. Fournie-Zaluski, and B.P. Roques Development of potent inhibitors of botulinum neurotoxin type B J. Med. Chem. 46 2003 4648 4656 (Pubitemid 37271614)
59. V. Roxas-Duncan, I. Enyedy, V.A. Montgomery, V.S. Eccard, M.A. Carrington, H. Lai, N. Gul, D.C. Yang, and L.A. Smith Identification and biochemical characterization of small-molecule inhibitors of Clostridium botulinum neurotoxin serotype A Antimicrob. Agents Chemother. 53 2009 3478 3486
60. R.A. Copeland Evaluation of Enzyme Inhibitors in Drug Discovery 2005 John Wiley Hoboken, NJ
61. M.A. Breidenbach, and A.T. Brunger Substrate recognition strategy for botulinum neurotoxin serotype A Nature 432 2004 925 929 (Pubitemid 40037157)
62. R. Pellizzari, O. Rossetto, L. Lozzi, S. Giovedi, E. Johnson, C.C. Shone, and C. Montecucco Structural determinants of the specificity for synaptic vesicle-associated membrane protein/synaptobrevin of tetanus and botulinum type B and G neurotoxins J. Biol. Chem. 271 1996 20353 20358 (Pubitemid 26281802)
63. V.V. Vaidyanathan, K. Yoshino, M. Jahnz, C. Dorries, S. Bade, S. Nauenburg, H. Niemann, and T. Binz Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, and E: domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage J. Neurochem. 72 1999 327 337 (Pubitemid 29013908)